Aegis Wealth Management (Maryland)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Buy
2,583
+106
+4% +$24.7K 0.31% 70
2026
Q1
$605K Sell
2,477
-224
-8% -$52.2K 0.35% 58
2025
Q4
$559K Sell
2,701
-333
-11% -$65.9K 0.32% 59
2025
Q3
$563K Sell
3,034
-352
-10% -$60.3K 0.3% 60
2025
Q2
$562K Sell
3,386
-330
-9% -$50.7K 0.34% 55
2025
Q1
$616K Buy
3,716
+330
+10% +$51.6K 0.36% 53
2024
Q4
$490K Buy
+3,386
New +$525K 0.33% 50

Other funds holding JNJ

Aegis Wealth Management (Maryland)'s JNJ Position: Q2 2026 in Review

Aegis Wealth Management (Maryland) increased its Johnson & Johnson (JNJ) stake by 4.3% in Q2 2026, buying an estimated $24.7K and bringing the position to 2,583 shares worth $656K. The position accounts for 0.31% of the portfolio, ranked #70.

Aegis Wealth Management (Maryland) first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aegis Wealth Management (Maryland) held 2,583 shares of Johnson & Johnson worth $656K as of Q2 2026.
  • Aegis Wealth Management (Maryland) bought 106 Johnson & Johnson shares in Q2 2026, an estimated $24.7K.
  • Johnson & Johnson made up 0.31% of Aegis Wealth Management (Maryland)'s portfolio in Q2 2026, its #70 holding.
  • Aegis Wealth Management (Maryland) first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q2 2026, filed 7 Aug 2026.